In its upcoming report, Kenvue (KVUE) is predicted by Wall Street analysts to post quarterly earnings of $0.25 per share, reflecting a decline of 19.4% compared to the same period last year. Revenues ...

Kenvue Inc . (NYSE:KVUE), the consumer health company spun off from Johnson & Johnson in 2023, finds itself at a critical juncture as it navigates its first full year as an independent entity. The ...

Kenvue Inc. closed 12.96% below its 52-week high of $24.46, which the company reached on November 26th.

Kenvue (NYSE:KVUE – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on ...

This was the stock's second consecutive day of gains.

Barclays analyst Lauren Lieberman maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report) today and set a price target of $21.00. The ...

L’Oréal veteran Penelope Giraud will lead the direction of the company’s beauty brands Neutrogena, Aveeno and Dr. Ci Labo in ...

Dakota Wealth Management raised its position in Kenvue Inc. (NYSE:KVUE – Free Report) by 25.6% during the 4th quarter, ...

Have you ever felt overlooked or unseen? Kenvue's Joy Ogunneye knows that feeling all too well. Back in college, while ...